FDA PMA FDA Class 2 Approved 🇺🇸 United States

Intervertebral Fusion Device With Bone Graft, Lumbar

PMA: P950002 · Supplement: S014 · Decision Jul 1, 2004
Classifications
1
FEI Numbers
422
Registration Numbers
422

Basic Information

Device Name
Intervertebral Fusion Device With Bone Graft, Lumbar
Trade Name
BAK VISTA INTERBODY FUSION CAGE
PMA Number
P950002
Supplement Number
S014
Device Class
FDA Class 2
Product Code
MAX
Generic Name
Intervertebral fusion device with bone graft, lumbar
Regulation Number
888.3080
Medical Specialty
Orthopedic
Advisory Committee
Orthopedic
Decision
Approved
Decision Code
APPR
Decision Date
July 1, 2004
Date Received
January 21, 2004
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL TO ADD THE FOLLOWING SIZES TO THE BAK VISTA DEVICE: 9X24 MM, 11X24 MM, 13X24 MM, 15X24 MM, 17X24 MM, 19X24 MM. THE BAK VISTA INTERBODY FUSION DEVICE, WHICH IS MANUFACTURED FROM 65% PEEK OPTIMA AND 35% TOHO BESFIGHT C6-UH CARBON FIBER, TO THE APPROVED PRODUCT LINE FOR THE BAK INTERBODY FUSION SYSTEM. THE DEVICE WILL BE MARKETED UNDER THE TRADE NAME BAK VISTA INTERBODY FUSION DEVICE AND IS INDICATED FOR USE WITH AUTOGENOUS BONE GRAFT IN PATIENTS WITH DEGENERATIVE DISC DISEASE (DDD) AT THE L2-S1 LEVELS. THESE DDD PATIENTS MAY ALSO HAVE UP TO GRADE I SPONDYLOLISTHESIS OR RETROLISTHESIS AT THE INVOLVED LEVELS. BAK DEVICES ARE TO BE IMPLANTED VIA AN OPEN ANTERIOR OR POSTERIOR APPROACH. DDD IS DEFINED AS DISCOGENIC BACK PAIN WITH DEGENERATION OF THE DISC CONFIRMED BY HISTORY AND RADIOGRAPHIC STUDIES. THESE PATIENTS WOULD BE SKELETALLY MATURE AND HAVE HAD SIX MONTHS OF NON-OPERATIVE TREATMENT.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MAX Intervertebral Fusion Device With Bone Graft, Lumbar